Overexpression of p53 and neoplastic cell proliferation in undifferentiated nasopharyngeal carcinoma

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 38, Issue 1, 2007, Pages 136-140

  Taweevisit, Mana ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947574924     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Agaoglu FY, Dizdar Y, Dogan O, et al. p53 overexpression in nasopharyngeal carcinoma. In Vivo 2004; 18: 555-60.
2. Baker SJ, Fearon ER, Nigra JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science 1989; 244: 217-21.
3. Burgos JS. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol 2005; 22: 113-21.
4. Buschmann T, Fuchs SY, Lee CG, Pan ZQ, Ronai Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 2000; 101: 753-62.
5. Chan ATC, Teo PML, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002; 13: 1007-15.
6. Chan JKC, Bray F, McCanon P, et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005: 85-97.
7. Chen MK, Lee HS, Chang JH, Chang CC. Expression of p53 protein and primary tumor volume in patients with nasopharyngeal carcinoma. J Otolaryngol 2004; 33: 304-7.
8. Cheng Q, Wei J, Huang X. Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Za Zhi 2005; 19: 643-5.
9. Cheng SH, Yen KL, Jian JJ, et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys 2001; 50: 717-26.
10. Harn HJ, Hsieh HF, Ho LI, et al. Apoptosis in nasopharyngeal carcinoma as related to histopathological characteristics and clinical stage. Histopathology 1998; 33: 117-22.
11. Iacopetta B. TP53 mutation in colorectal cancer. Hum Mutat 2003; 21: 271-76.
12. Jayasurya A, Bay BH, Yap WM, Tan NG, Tan BKH. Proliferative potential in nasopharyngeal carcinoma: correlations with metallothionein expression and tissue zinc level. Carcinogenesis 2000; 21: 1809-12.
13. Johnson FM, Garden AS, Palmer JL, et al. A phase I/III study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2005; 63: 717-24.
14. Liu YH, Du CL, Lin CT, Chan CC, Chen CJ, Wang JD. Increased morbidity from nasopharyngeal carcinoma and chronic pharyngitis or sinusitis among workers at a newspaper printing company. Occup Environ Med 2002; 59: 18-22.
15. Lopez-Crapez E, Bibeau F, Thezenas S, et al. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer 2005; 92: 2114-21.
16. Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 1998; 83: 582-8.
17. Masuda M, Shinokuma A, Hirakawan N, Nakashima T, Komiyama S. Expression of bcl-2, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment. Head Neck 1998; 20: 640-4.
18. M'Rabti H, Sbiti Y, Afqir S, Boutayeb S, Errihani H. Chemotherapy in nasopharyngeal carcinoma. Ann Otolaryngol Chir Cervicofac 2006; 123: 59-64.
19. Reddy SP, Raslan WF, Gooneratne S, et al. Prognostic significance of keratinisation in nasopharyngeal carcinoma. Am J Otolaryngol 1995; 16: 1038.
20. Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997; 37: 985-96.
21. Shi W, Pataki I, MacMillan C, et al. Molecular pathology parameters in human nasopharyngeal carcinoma. Cancer 2002; 94: 1997-2006.